|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy ( CA184-043 ): a multicentre, randomised, double-blind, phase 3 trial 显示文摘 | Kwon ED Drake CG Scher HI | 2014 | Lancet Oncol2014，15，7： | 1 |
| 2 | Ipilimumab versus placebo after radiotherapy in patients with metastatic castration - resistant- prostate cancer that had progressed afler docetaxel chemotherapy (CA184 - 043 ) : A muhicentre, randomised, double - blind, phase 3 trial显示文摘 | Kwan ED Drake CG Scher HI | 2014 | UrolOnco12014，15，7： | 1 |
| 3 | Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy(CA184-043):a multicentre,randomised,double-blind,phase 3trial显示文摘 | Kwon ED Drake CG Scher HI | 2014 | Lancet Oncol2014，15，7： | 1 |
| 4 | Ipilimumab versus placebo after radiotherapy in patients with metastatic castrationresistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): amulticentre, randomised, doubleblind, phase 3 trial显示文摘 | KWON ED DRAKE CG SCHER HI | 2014 | Lancet Oncol2014，15，7： | 1 |
| 5 | Technical aspects of radiation thera py for anal cancer显示文摘 | Scher ED Ahmed I Yue NJ | 2014 | J Gastruintest Oncol2014，5，3： | 1 |
| 6 | Ambulatory pulse oximetry as a clinical aid for the diagnosis and treatment response of radiation pneumonitis显示文摘 | Scher ED Kim S Deck MP | 2015 | Pract Radiat Oncol2015，5，6： | 1 |
| 7 | Ipilimumab versus placebo after radiotherapy in patients with metastatic castration- resistant prostate cancer that had progressed after docetaxel chem- otherapy ( CA184-043 ) : a muhicentre, randomised, double- blind, phase3 trial显示文摘 | KWON ED DRAKE CG SCHER HI | 2014 | Lancet Oncol2014，15，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员